[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100583149":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":11,"centralContacts":28,"locations":34,"responsibleParty":49,"collaborators":51,"id":55,"slug":11,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":56,"sex":62,"minAge":63,"maxAge":11,"enrollmentInfo":64,"targetDuration":11,"studyType":67,"phases":68,"briefSummary":70,"conditions":71,"keywords":11,"overallStatus":37,"whyStopped":11,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"North American Science Associates Ltd.","NETWORK",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Control","ACTIVE_COMPARATOR",null,[13],"Drug: Corticosteroid Injection",{"label":15,"type":16,"description":11,"interventionNames":17},"Device: GAE","EXPERIMENTAL",[18],"Device: genicular artery embolization",[20,24],{"type":21,"name":22,"description":22,"armGroupLabels":23,"otherNames":11},"DEVICE","genicular artery embolization",[15],{"type":25,"name":26,"description":26,"armGroupLabels":27,"otherNames":11},"DRUG","Corticosteroid Injection",[9],[29],{"name":30,"role":31,"phone":32,"phoneExt":11,"email":33},"Ziv J Haskal, MD","CONTACT","16463691570","haskalembo@gmail.com",[35],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":11},"University of Virginia","RECRUITING","Charlottesville","Virginia","22903","United States","US",{"type":44,"coordinates":45},"Point",[46,47],-78.47668,38.02931,{"lat":47,"lon":46},{"type":50,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[52],{"name":53,"class":54},"Next Biomedical Co., Ltd.","INDUSTRY","100583149",false,"NCT06872567","Randomized Controlled Study Evaluating Genicular Artery Embolization Against Intra-Articular Corticosteroid Knee Injection for Osteoarthritic Knee Pain","Resorbable Embolization MicroSpheres for OsteoaRthritis Benefit","RESORB","Inclusion Criteria:\n\n* Patient has localized knee pain\n* Must be an appropriate candidate for arterial vascular access procedure\n\nExclusion Criteria:\n\n* Known sensitivity or allergy to implant materials\n* Unable or unwilling to comply with study requirements","ALL","40 Years",{"count":65,"type":66},126,"ESTIMATED","INTERVENTIONAL",[69],"NA","Multi-center, prospective, randomized trial of GAE using Nexsphere-F against steroid injection",[72],"Knee Osteoarthritis (Knee OA)","2025-11-19",{"date":75,"type":76},"2025-11-24","ACTUAL",{"date":78,"type":76},"2025-10-01",{"date":80,"type":66},"2026-12",{"name":5,"class":6},1]